Primary post‐transplant lymphoproliferative disorder of the central nervous system: characteristics, management and outcome in 25 paediatric patients-Reference-Cited by-同舟云学术

Primary post‐transplant lymphoproliferative disorder of the central nervous system: characteristics, management and outcome in 25 paediatric patients

Published:2021-03-25 Issue:6 Volume:193 Page:1178-1184
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br. J. Haematol.

Author:

Taj Mary M.¹,Maecker‐Kolhoff Britta²,Ling Rebecca³,Bomken Simon⁴,Burkhardt Birgit⁵^ORCID,Chiang Alan K. S.⁶^ORCID,Csoka Monika⁷,Füreder Anna⁸,Haouy Stéphanie⁹,Lazic Jelena¹⁰,Miakova Natalia¹¹,Minard‐Colin Veronique¹²,Turner Suzanne D.¹³¹⁴^ORCID,Uyttebroeck Anne¹⁵,Attarbaschi Andishe⁸^ORCID,

Affiliation:

1. Department of Pediatric Hematology and Oncology Royal Marsden Hospital NHS Foundation Trust London UK

2. Department of Pediatric Hematology and Oncology Hannover Medical School Hannover Germany

3. MRC Weatherall Institute of Molecular Medicine University of OxfordJohn Radcliffe Hospital OxfordUK

4. Wolfson Childhood Cancer Research Center Translational and Clinical Research InstituteNewcastle University Newcastle upon Tyne UK

5. Department of Pediatric Hematology and Oncology University of Münster Münster Germany

6. Department of Pediatrics and Adolescent Medicine Li Ka Shing Faculty of Medicine The University of Hong KongQueen Mary Hospital Pokfulam Hong Kong

7. 2^nd Department of Pediatrics Semmelweis University Budapest Hungary

8. Department of Pediatric Hematology and Oncology St. Anna Children's HospitalMedical University of Vienna Vienna Austria

9. Department of Pediatric Hematology and Oncology Centre Hospitalier Universitaire de Montpellier Montpellier France

10. Department of Pediatric Hematology and Oncology University Children's HospitalSchool of Medicine University of Belgrade Belgrade Serbia

11. Department of Pediatric Hematology and Oncology Federal Center for Pediatric Hematology, Oncology and Immunology Moscow Russia

12. Department of Pediatric and Adolescent Oncology INSERM U1015Gustave‐Roussy Université Paris‐Sacaly University Villejuif France

13. Department of Pathology Division of Cellular and Molecular Pathology University of Cambridge Cambridge UK

14. Central European Institute of TechnologyMasaryk University Brno Czech Republic

15. Department of Pediatric Hematology and Oncology University Hospital Leuven Leuven Belgium

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjh.17398

Reference17 articles.

1. Posttransplant lymphoproliferative disorders: summary of society for hematopathology workshop;Harris NL;Semin Diagn Pathol,1997

2. Posttransplant lymphoproliferative disease after pediatric solid organ transplantation;Mynarek M;Clin Dev Immunol,2013

3. CNS or Bone Marrow Involvement As Risk Factors for Poor Survival in Post-Transplantation Lymphoproliferative Disorders in Children After Solid Organ Transplantation

4. Posttransplant Lymphoproliferative Disorder: Significance of Central Nervous System Involvement

5. Primary central nervous system post-transplantation lymphoproliferative disorder

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Post‐transplant lymphoproliferative disease in children, adolescents, and young adults;Hematological Oncology;2023-06

2. Diagnosis and management of post-transplant lymphoproliferative disease following solid organ transplantation in children, adolescents, and young adults;Best Practice & Research Clinical Haematology;2023-03

3. Multicenter study of pediatric Epstein‐Barr virus–negative monomorphic post solid organ transplant lymphoproliferative disorders;Cancer;2022-12-26

4. Recent Advances in Adult Post-Transplant Lymphoproliferative Disorder;Cancers;2022-12-01

5. Successful Treatment of Central Nervous System Involvement in Posttransplant EBV-related Lymphoproliferative Disease With Intrathecal Rituximab Therapy;Journal of Pediatric Hematology/Oncology;2022-11-15